BCG in perspective: advances in the treatment of superficial bladder cancer.

@article{Lamm1995BCGIP,
  title={BCG in perspective: advances in the treatment of superficial bladder cancer.},
  author={Donald L. Lamm},
  journal={European urology},
  year={1995},
  volume={27 Suppl 1},
  pages={2-8}
}
The management of superficial bladder cancer has advanced significantly in recent years. Controlled clinical trials suggest the benefits of cytotoxic chemotherapy apply primarily to well-differentiated tumours, are short-term and do not include a reduction in disease progression. In contrast, intravesical bacillus Calmette-Guérin (BCG) immunotherapy is effective in high-grade tumours, provides long-term protection from tumour recurrence and reduces disease progression. Controlled clinical… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

The origins of urothelial carcinoma.

Expert review of anticancer therapy • 2010

Similar Papers

Loading similar papers…